Vycor Medical (VYCO) Net Income towards Common Stockholders (2022 - 2023)
Vycor Medical (VYCO) has disclosed Net Income towards Common Stockholders for 6 consecutive years, with -$214089.0 as the latest value for Q3 2023.
- Quarterly Net Income towards Common Stockholders rose 22.71% to -$214089.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was -$301006.0 through Dec 2023, up 50.57% year-over-year, with the annual reading at -$755.0 for FY2022, N/A changed from the prior year.
- Net Income towards Common Stockholders for Q3 2023 was -$214089.0 at Vycor Medical, down from $68406.0 in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $68406.0 in Q2 2023, with the low at -$276992.0 in Q3 2022.